Adenoviral-mediated transfer of Escherichia coli uracil phosphoribosyltransferase (UPRT) gene to modulate the sensitivity of the human colon cancer cells to 5-fluorouracil

European Journal of Cancer

Volumn 36, Issue 18, 2000, Pages 2403-2410

  Koyama, F ^a   Sawada, H ^a   Fujii, H ^a   Hamada, H ^b   Hirao, T ^a   Ueno, M ^a   Nakano, H ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

5 Fluorouracil; Adenoviral vector; Gene therapy; Uracil phosphoribosyltransferase

Indexed keywords

DNA; FLOXURIDINE PHOSPHATE; FLUOROURACIL; FLUOROURIDINE; RNA; THYMIDYLATE SYNTHASE INHIBITOR; URACIL PHOSPHORIBOSYLTRANSFERASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CHEMOSENSITIVITY; COLON CANCER; CONTROLLED STUDY; DRUG ACTIVATION; DRUG METABOLISM; ENZYME INHIBITION; ESCHERICHIA COLI; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RNA BINDING;

ADENOVIRIDAE; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; COLONIC NEOPLASMS; ESCHERICHIA COLI; FLUOROURACIL; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; MICE; MICE, NUDE; PENTOSYLTRANSFERASES; TUMOR CELLS, CULTURED;

EID: 0033696046     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00338-5     Document Type: Article

References (31)

1. Fluorouracil: Biochemistry and pharmacology
2. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines
3. Disruption of p53 in human cancer cells alters the responses to therapeutic agents
4. Response to fluorouracil therapy in cancer patients: The role of tumoral dihydropyrimidine dehydrogenase activity
5. A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil
6. Chemothrapy for colorectal cancer
7. Biochemical modulation as an approach to reversal of antimetabolite resistance
8. Adjuvant therapy for colorectal cancer. Present and future perspectives
9. Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: Results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients
10. The S-1 Gastrointestinal Cancer Study Group. An early phase II study of oral S-1, a newly developed 5-fluorouracil derivative for advanced and recurrent gastrointestinal cancers
11. In vivo adenovirus-medited gene transfer of the Escherichia coli cytosine deaminase to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine
12. Tumor-specific gene expression in carcinoembryonic antigen-producing gastric cancer cells using adenovirus vectors
13. Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine
14. An HSVtk-mediated local and distant antitumor bystander effect in tumors of head and neck origin in athymic mice
15. In vivo gene therapy for a-fetoprotein producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene
16. Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase
17. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration
18. Characterization of the upp gene encoding uracil phosphoribosyltransferase of Escherichia coli K12
19. Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyltransferase gene sensitizes cancer cells to low concentrations of 5-fluorouracil
20. Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction
21. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase
22. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing full-length virus genome
23. Efficient selection for high-expression transfectants with a novel eukaryotic vector
24. Detection of wild-type contamination in a recombinant adenoviral preparation by PCR
25. Differential motility stimulation but not growth stimulation or adhesion of metastatic human colorectal carcinoma cells by target organ-derived liver sinusoidal endothelial cells
26. Biochemical determinants of tumor sensitivity to 5-fluorouracil: Ultrasensitive methods for determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthetase
27. Quantification of 5-fluorouracil incorporation into RNA of human and murine tumors as mesured with a sensitive gas chromatography-mass spectometry assay
28. In vivo kinetics of thymidylate synthetase inhibition in 5-fluorouracil-sensitive and-resistant murine colon adenocarcinomas
29. Gene therapy: Applications to the treatment of gastrointestinal and liver diseases
30. Plasma CEA, tumor CEA, and tumor histology